Constitutional debate | Donald Trump's second impeachment trial opens in the Senate today with a fight over whether Congress can convict a former president of a crime. If all 50 Democrats agree that it can, both House impeachment managers and Trump's defense team will begin their cases tomorrow. At least 17 Republicans would have to vote for conviction to reach the required two-thirds majority. - President Joe Biden's Justice Department is preparing to ask most U.S. attorneys appointed by Trump to resign.
Fast track | Biden and White House officials are siding with liberal Democrats frustrated by past failures to reach compromise with Republicans and are refusing to heed GOP appeals to scale back the administration's $1.9 trillion stimulus. As Mario Parker and Nancy Cook report, they're likely to push the package through under a procedure that requires only simple majority support in the Senate. - Biden's administration has dedicated its first few weeks in office to spending more money on pandemic relief, shrugging off warnings the economy may overheat.
- Support is rising among policy makers to address America's worsening child-poverty crisis.
Collision course | Myanmar's police toughened their stance against anti-coup protesters, firing rubber bullets at crowds in the capital Naypyidaw, blasting tear gas and water cannons at demonstrations in Mandalay and threatening protesters in Yangon with violence unless they dispersed. The youth-led pro-democracy movement — on the streets in their tens of thousands in defiance of martial law — is at risk of a violent confrontation with a military that has a history of deadly crackdowns. Green lane | With millions being vaccinated against Covid-19 every day, some political and business leaders are suggesting nations can help get life back to normal by rolling out a so-called vaccine passport: an easily accessible and verifiable certification that a person's been inoculated. A handful of projects from governments, private firms and international associations are underway. But the idea raises scientific and ethical questions. - The U.K.'s plan for "surge testing" to detect and suppress new virus variants is unlikely to work unless done on a larger scale, a scientific adviser says.
Vote watch | Elections are set to dominate the political calendar in emerging and frontier markets in a year when investors are focusing on how fast governments can lift their economies out of the pandemic-induced global downturn. We took a spin through the emerging market timeline to assess how the ballots may help determine the winners — and the laggards. An anti-government demonstration in Sofia, Bulgaria, in September. Photographer: NIKOLAY DOYCHINOV/AFP What to WatchAnd finally ... One is a seasoned public speaker, as comfortable debating his Davos counterparts in English as he is explaining the potential side effects of coronavirus vaccines. The other is Japan's prime minister. As Isabel Reynolds reports, just as Yoshihide Suga faces a pivotal moment in his leadership, he's being eclipsed by cabinet member Taro Kono, appointed three weeks ago to lead the country's inoculation rollout. Kono at a drill by Japan's Ground Self-Defense Forces in Gotemba last May. Photographer: Charly Triballeau/AFP |
Post a Comment